News
LYON, France, July 02, 2025--MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe ...
MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies TM (MET) dedicated to enhancing survival ...
Siân Crouzet, COO/ CFO +33 4 28 29 14 00 invest@maat-pharma.com MaaT Pharma – Media Relations Pauline RICHAUD Senior PR & Corporate Communications Manager +33 6 14 06 45 92 prichaud@maat-pharma.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback